CCI vs ISPC · P/E 40, rev $6.57B vs rev $9.3M
Crown Castle (CCI) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the CCI and ISPC stock pages for the full models.
Not investment advice.